Research Programs: Cancer Outcomes and Survivorship, Women's Cancer
Assistant Professor, Department of Obstetrics and Gynecology

ghebr004@umn.edu
612-626-5939 — office
Preferred method of contact: e-mail

Dr. Ghebre's clinical profile
(University of Minnesota Physicians Web site)

Dr. Rahel Ghebre is an assistant professor in the Division of Gynecologic Oncology within the Department of Obstetrics, Gynecology and Women's Health. Her clinical practice involves caring for women with ovarian, endometrial, cervical, vulvar and vaginal cancer at the University of Minnesota Women's Health Clinic. Dr. Ghebre is the gynecologic specialist for the University of Minnesota Fanconi Anemia Comprehensive Care program.

Dr. Ghebre received her M.D. degree at the University of Michigan. She completed her residency in obstetrics and gynecology, and fellowship in gynecologic-oncology at the University of Minnesota in 2004. She then joined as a faculty member in the Division of Gynecologic Oncology in 2005. Dr. Ghebre is board certified in obstetrics and gynecology.

Dr. Ghebre's research is focused on clinical trials in the field of gynecologic oncology and cancer prevention. She is active as co-investigator on clinical trials for ovarian and endometrial cancer. As an NIH-BIRCWH 2008 scholar, Dr. Ghebre is investigating cervical cancer prevention for underscreened populations of women.

Selected Publications

Subramanian IV, Ghebre R, Ramakrishnan S. Adeno-associated virus mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice. Gene Therapy 12(1):30-38, 2005 Jan

Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr, Carson LF. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up. Eur J Gynaecol Oncol 27(3):231-235, 2006.

Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: A retrospective analysis and literature review. Gynecol Oncol 107(1):79-85, 2007 Oct.

Downs LS Jr, Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF. A prospective randomized trial of Thalidomide with Topotecan compared to Topotecan alone in women with recurrent epithelial ovarian carcinoma. Cancer 2008, Jan 15;112(2);331-9.

Argenta PA, Ormsby RR, Downs LS Jr, Judson PL, Ghebre R, Carson LF. Routine pelvic examination during front line chemotherapy for ovarian cancer: Is there a role? J Reprod Med 53 (1):3-7, 2008.